Literature DB >> 15721732

The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.

Ashraf S Habib1, Tong J Gan.   

Abstract

STUDY
OBJECTIVES: To compare the effectiveness of treating established postoperative nausea and vomiting (PONV) with an antiemetic acting at a different receptor with that of treating PONV with the antiemetic used for prophylaxis.
DESIGN: Analysis of data collected in a previously published randomized, double-blind, placebo-controlled study.
SETTING: Outpatient surgical procedures from 50 institutions in North America. PATIENTS: Patients (N = 2061) undergoing outpatient surgical procedures planned to last no more than 2 hours.
INTERVENTIONS: Patients were randomized to receive ondansetron 4 mg, droperidol 1.25, droperidol 0.625 mg, or placebo. In the postoperative anesthesia care unit, patients who developed PONV received rescue antiemetics at the discretion of the attending anesthesiologist. The following antiemetics were used for rescue: ondansetron 4 mg, droperidol 0.625 to 1.25 mg, metoclopramide 10 mg, promethazine 6.25 to 25 mg, and dimenhydrinate 25 to 50 mg. MEASUREMENTS: The complete response rate (no nausea, no emesis, and no need for further rescue) after administration of the rescue antiemetic in patients with established PONV was calculated. The complete response rate after administration of each of the different rescue antiemetics was compared with that after administration of the same antiemetic used for PONV prophylaxis. MAIN
RESULTS: In patients who failed prophylaxis with ondansetron 4 mg, the complete response rate was significantly higher (P = .02) after rescue with promethazine 6.25 to 25 mg (78%) than after rescue with ondansetron 4 mg (46%). In patients who failed prophylaxis with droperidol 0.625 and 1.25 mg, the complete response rate was significantly higher after rescue with promethazine 6.25 to 25 mg (77%; P = .02) and dimenhydrinate 25 to 50 mg (78%; P = .04) than after rescue with droperidol 0.625 to 1.25 mg (56%).
CONCLUSION: In patients who failed prophylaxis with ondansetron or droperidol, promethazine was significantly more effective than the agent used for prophylaxis for the treatment of PONV. In patients who failed prophylaxis with droperidol, dimenhydrinate was also more effective than droperidol for the treatment of established PONV in the postoperative anesthesia care unit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721732     DOI: 10.1016/j.jclinane.2004.04.004

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  13 in total

Review 1.  Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

Authors:  Dirk Rüsch; Leopold H J Eberhart; Jan Wallenborn; Peter Kranke
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

2.  Postdischarge Nausea and Vomiting Remains Frequent After Le Fort I Osteotomy Despite Implementation of a Multimodal Antiemetic Protocol Effective in Reducing Postoperative Nausea and Vomiting.

Authors:  Carolyn Dicus Brookes; Timothy A Turvey; Ceib Phillips; Vincent Kopp; Jay A Anderson
Journal:  J Oral Maxillofac Surg       Date:  2015-01-29       Impact factor: 1.895

3.  Multimodal protocol reduces postoperative nausea and vomiting in patients undergoing Le Fort I osteotomy.

Authors:  Carolyn Dicus Brookes; John Berry; Josiah Rich; Brent A Golden; Timothy A Turvey; George Blakey; Vincent Kopp; Ceib Phillips; Jay Anderson
Journal:  J Oral Maxillofac Surg       Date:  2014-08-11       Impact factor: 1.895

4.  [Low-dose droperidol in children: rescue therapy for persistent postoperative nausea and vomiting].

Authors:  E Schroeter; A Schmitz; T Haas; M Weiss; A C Gerber
Journal:  Anaesthesist       Date:  2012-01-12       Impact factor: 1.041

5.  Intravenous buspirone for the prevention of postoperative nausea and vomiting.

Authors:  Peter Kranke; Kerstin D Röhm; Pierre Diemunsch; Tong J Gan; Christian C Apfel; Leopold Eberhart; Harold S Minkowitz; Jan Wallenborn; Dominique Chassard; Gilles Lebuffe; Gabriel M Fox; Martin R Tramèr
Journal:  Eur J Clin Pharmacol       Date:  2012-05-01       Impact factor: 2.953

Review 6.  An update on the management of postoperative nausea and vomiting.

Authors:  Xuezhao Cao; Paul F White; Hong Ma
Journal:  J Anesth       Date:  2017-04-28       Impact factor: 2.078

Review 7.  [Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].

Authors:  C C Apfel; P Kranke; S Piper; D Rüsch; H Kerger; M Steinfath; K Stöcklein; D R Spahn; T Möllhoff; K Danner; A Biedler; M Hohenhaus; B Zwissler; O Danzeisen; H Gerber; F-J Kretz
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

Review 8.  Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.

Authors:  Charles C Horn; William J Wallisch; Gregg E Homanics; John P Williams
Journal:  Eur J Pharmacol       Date:  2013-10-26       Impact factor: 4.432

Review 9.  Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting.

Authors:  Zhaosheng Jin; Neil Daksla; Tong J Gan
Journal:  Drugs       Date:  2021-06-09       Impact factor: 9.546

10.  Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP).

Authors:  H K Ruben Thanacoody; Alasdair Gray; James W Dear; Judy Coyle; Euan A Sandilands; David J Webb; Steff Lewis; Michael Eddleston; Simon Hl Thomas; D Nicholas Bateman
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-04       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.